Literature DB >> 1002297

Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvant.

F Audibert, L Chedid.   

Abstract

A water-soluble fraction (WSA) of the cell wall can substitute for mycobacterial cells in Freund complete adjuvant. However, when WSA is administered in saline instead of in a water-in-oil emulsion, its adjuvant activity is very weak, and under certain experimental conditions it can even inhibit the humoral immune response. The data reported in the present study show that after treatment by phthalic or succinic anhydride the adjuvant activity of WSA was markedly changed, since high levels of circulating antibodies were produced when these derivatives were administered with an antigen in an aqueous medium. Moreover, the antigenic determinants of WSA were modified and acylated WSA had no tuberculin-like activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1002297      PMCID: PMC415525          DOI: 10.1128/iai.14.6.1263-1268.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  C Merser; P Sinay; A Adam
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

2.  Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.

Authors:  I J Hiu
Journal:  Nat New Biol       Date:  1972-08-23

3.  The adjuvant activity of a mycobacterial water soluble adjuvant (WSA) in vitro. I. The requirement of macrophages.

Authors:  M Modolell; G A Luckenbach; M Parant; P G Munder
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

4.  Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer; L Chedid; A Lamensans; F Parant; M Parant; J P Rosselet; F M Berger
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

5.  The enhancement of antibody formation by Escherichia coli lipopolysaccharide and detoxified derivatives.

Authors:  J R Schenck; M P Hargie; M S Brown; D S Ebert; A L Yoo; F C McIntire
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

Review 6.  Critical appraisal of emulsified oil adjuvants applied to viral vaccines.

Authors:  M R Hilleman
Journal:  Prog Med Virol       Date:  1966

7.  Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans.

Authors:  J Fleck; M Mock; F Tytgat; C Nauciel; R Minck
Journal:  Nature       Date:  1974-08-09       Impact factor: 49.962

8.  Biological activities of endotoxins detoxified by alkylation.

Authors:  L Chedid; F Audibert; C Bona; C Damais; F Parant; M Parant
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

9.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT.

Authors:  D E Stewart-Tull; T Shimono; S Kotani; M Kato; Y Ogawa; Y Yamamura; T Koga; C M Pearson
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.